CervoMed Inc.

• locale

  United States

• market

  STOCKS

• industry

  Biotechnology

• website

  www.cervomed.com

• ipo date

  May 23, 2008

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. It develops neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, and brain stroke recovery. The company is based in Boston, Massachuse...Show More